Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Intangibles: 2021-2025

Historic Intangibles for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $180.8 million.

  • LifeStance Health's Intangibles fell 747.32% to $180.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.8 million, marking a year-over-year decrease of 747.32%. This contributed to the annual value of $190.8 million for FY2024, which is 1369.37% down from last year.
  • LifeStance Health's Intangibles amounted to $180.8 million in Q3 2025, which was down 747.32% from $184.0 million recorded in Q2 2025.
  • LifeStance Health's Intangibles' 5-year high stood at $359.1 million during Q2 2021, with a 5-year trough of $180.8 million in Q3 2025.
  • For the 5-year period, LifeStance Health's Intangibles averaged around $243.1 million, with its median value being $238.7 million (2023).
  • In the last 5 years, LifeStance Health's Intangibles tumbled by 2145.17% in 2022 and then crashed by 747.32% in 2025.
  • Quarter analysis of 5 years shows LifeStance Health's Intangibles stood at $300.4 million in 2021, then dropped by 12.34% to $263.3 million in 2022, then decreased by 16.04% to $221.1 million in 2023, then dropped by 13.69% to $190.8 million in 2024, then fell by 5.27% to $180.8 million in 2025.
  • Its Intangibles was $180.8 million in Q3 2025, compared to $184.0 million in Q2 2025 and $187.3 million in Q1 2025.